Cara Therapeutics reported $3.39M in Trade Creditors for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 9.06M 0.22M
Acelrx Pharmaceuticals ACRX:US $ 1.94M 1.29M
Aerie Pharmaceuticals AERI:US $ 7.44M 0.92M
Antares Pharma ATRS:US $ 15.8M 0.97M
Arena Pharmaceuticals ARNA:US $ 3.78M 5.76M
Biodelivery Sciences International BDSI:US $ 4.07M 1.23M
Cara Therapeutics CARA:US $ 3.39M 1.38M
Chugai Pharma 4519:JP Y 138262M 31451M
Depomed DEPO:US $ 16.48M 5.87M
Endo International Ordinary Shares ENDP:US $ 103.84M 0.68M
Halozyme Therapeutics HALO:US $ 4.56M 4.03M
Horizon Pharma HZNP:US $ 51.95M 8.96M
JAZZ PHA JAZZ:US $ 64.83M 12.91M
Pacira Pharmaceuticals PCRX:US $ 12.18M 3.07M
Pain Therapeutics PTIE:US $ 1.91M 1.05M
Redhill Biopharma RDHL:US $ 28.22M 11.35M
Revance Therapeutics RVNC:US $ 8.18M 1.1M
Teva Pharmaceutical Industries TEVA:US $ 1514M 37M
Vanda Pharmaceuticals VNDA:US $ 5.92M 0.6M